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Spinal manipulation versus an effective sham for non-specific low back pain: a 
systematic review and meta-analysis. 
Jay K Ruddock M.Ost a, Hannah Sallis MSc b, c, Andy Ness PhD d, Rachel E Perry 
MPhil 
ABSTRACT 
Purpose: Non-specific low back pain (NSLBP) is a common and costly condition which 
will affect the majority of people in their lifetime.  Successful treatment of this condition 
would be of great benefit to the general population.  Spinal manipulation (SM) has been 
suggested as an effective treatment. However, there is still debate over whether the 
supposed benefit is due to specific treatment effects or a non-specific ‘placebo effect’. 
Issues around safety of the technique have also been raised. 
This review seeks to systematically identify and critically evaluate all randomised 
controlled trials (RCTs) of SM in the treatment of NSLBP utilising an effective sham 
manipulation.  Methods: Five electronic databases were searched from their inception 
to March 2015 to identify all relevant trials.  Reference lists of retrieved articles were 
hand-searched. All data was extracted by two independent reviewers and risk of bias 
was assessed using the Cochrane back group Risk of Bias tool (2009). 
Results: Nine RCTs were included in the systematic review and four were found to be 
eligible for inclusion in a meta-analysis. Participants in the SM group had improved 
symptoms compared with participants receiving sham treatment (SMD=-0.36; 95% CI -
0.59,-0.12).  The majority of studies were of low risk of bias, however several of the 
studies were small, the practitioner could not be blinded, some studies did not conduct 
intention-to-treat (ITT) analysis and had a high level of drop outs. Conclusions: Thus 
given the small number of studies included in this analysis, we should be cautious of 
making strong inferences based on these results.  
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INTRODUCTION 
Over the course of a lifetime approximately 80% of people will experience low back 
pain (LBP). Non-specific low back pain (NSLBP) is the second most common reason 
for worker absenteeism1,2 and is the most common reason to attend a manual therapy 
clinic.3,4  
NSLBP is characterised by pain in the posterior lumbar spine, sacral spine or para-
spinal tissues which may be accompanied by decreased range of motion.5 The 
aetiology is unclear and a definitive cause remains elusive for researchers.6 Several 
different approaches to treatment have been identified, with mixed evidence for their 
success.7,8,9 One of the treatments widely used is spinal manipulation (SM).   
 
Spinal Manipulation and Mobilisation 
SM can be defined as “treatments that use high velocity/low amplitude (HVLA) to move 
a joint that is exhibiting somatic dysfunction through its restrictive barrier.” Several 
models suggest that this technique would be able to produce a hypo-analgesic effect, 
either by structural11,12,13 or neurological processes,14,15 whilst others have postulated it 
acts through non-specific or ‘placebo’ effects.16,17  
In contrast, spinal mobilisation uses low velocity/low amplitude cyclical techniques 
(non-thrust mobilisation); it has been argued that this method of action differs from that 
of HVLA techniques, thus mobilisation and manipulation should be investigated 
separately.18 SM can have serious (although very rare) adverse outcomes such as 
intervertebral disc prolapse and fracture,19 whereas there are no reported adverse 
events reported from receiving non-thrust spinal mobilisation.5 If it could be established 
that there were no specific treatment benefits from HVLA techniques on NSLBP then it 
would be inappropriate to perform them on patients.   
 
Controlling the Placebo Effect in Trials of SM 
 In order to exclude possible placebo effects in trials of SM, the control group must 
either be screened for previous experience of SM,20 or be exposed to an effective 
sham intervention.    
There is little agreement among experts as to what constitutes an effective sham 
manipulation.21 However, there is some evidence as to what may be acceptable as an 
effective sham manipulation of the lumbar spine. Hancock et al (2006)21 demonstrated 
the most credible sham procedure was Maitland’s ‘log roll.’22 This procedure comprises 
‘placing the patient in a side-lying position and placing the physiotherapist’s hands over 
the over the lower ribs and ilium. The pelvis and trunk are then rolled together so no 
lumbar inter-vertebral motion occurs’ (Hancock 2006 p136). 
Fulda et al (2007)23 showed participants videos of side-lying SM, light touch or 
ultrasound to gauge patients’ perceptions of treatments for lumbar spine pain. The 
participants viewed SM as the therapy most likely to reduce pain and improve function, 
suggesting that a sham needs to physically resemble a SM technique for it to be 
believable. Hawk and Long (2000)24 and Machado et al (2008)25 also identified the 
importance of equalization of the non-specific effect of physical touch between 
participants. The use of an indistinguishable placebo should counteract any subtle 
differences between groups shown to influence treatment outcomes.26,27 Other active 
therapies are not considered a viable control as they can lead to erroneous 
interpretation due to varied contextual factors which produce a placebo effect or 
specific treatment effects.28 Thus, for a sham manipulation to be an effective control it 
should physically resemble a HVLA technique and be performed so as to eliminate 
subtle differences between the intervention group and the control group. For the 
purpose of this review the term “effective” sham control is used to denote control 
groups that met these criteria. 
Previous reviews have compared SM to sham manipulations, however they have either 
included papers that did not utilise an effective sham7 or they permitted techniques that 
were not solely HVLA.7,29,30,31  
Bronfort et al’s (2010)7 review compared SM to a sham intervention. However, one 
included study88 used an inappropriate sham intervention by using gluteal massage.  
Rubenstein et al’s (2011)30 review of SM for chronic low back pain included one study32 
which used several techniques (HVLA, muscle energy techniques, soft tissue 
manipulation, fascial manipulation and cranio-sacral) in their treatment group. 
Rubenstein et al’s (2012)31 review of SM for acute back pain only included one study of 
SM versus a sham intervention. None of these reviews distinguished between SM and 
mobilisation. 
Ernst and Harkness’s (2001 p. 887)17 review of SM for a range of conditions identified 
three trials33,34,89 and recommended that ‘the specific efficacy of SM for low back pain 
must await adequately designed sham-controlled trials’.  The most recent systematic 
review35 examined SM, mobilisation and exercise as separate interventions against 
shams in NSLBP sufferers of various durations.  Five studies were analysed in groups 
determined by similarity of patients, interventions, comparisons and outcomes.  
However, no meta-analysis was performed. 
This systematic review critically evaluates data from randomised controlled trials 
(RCTs) using HVLA techniques for people with NSLBP.  The aim is to assess SM in 
isolation rather than as part of a treatment package of care. Any specific treatment 
effects or adverse events that are identified can be isolated to SM. To be eligible, the 
comparison group had to be an effective sham.  
 
METHODS 
The following databases were searched from their inception to March 2015: MEDLINE 
and AMED (via Ovid), Web of Science and Central via Cochrane library, using a 
combination of MeSH and key word terms (see Appendix 1 for the search strategy). No 
restrictions were applied regarding language or date. Reference lists of all full-text 
articles and all relevant systematic reviews were hand-searched for additional studies.  
A protocol was produced and can be found at http://www.crd.york.ac.uk/PROSPERO/, 
reg number CRD42014008886. 
 
Study selection 
All titles and abstracts retrieved from the searches were assessed for eligibility.   
Articles that appeared to meet the inclusion criteria were retrieved in full and 
independently considered for inclusion by two reviewers (JR, RP). Disagreements were 
resolved through discussion (see Fig 1 for flow diagram).  The following inclusion 
criteria were predefined:  
Type of Participant Participants of either gender and >18 years with NSLBP  
Type of Intervention Randomised controlled trials (RCTs) which used HVLA SM as an 
intervention. Studies which either screen for subject expectation of SM, or assess for 
effective blinding after the intervention, were also included. 
Type of Comparator Studies which have an effective sham control i.e. the physical act 
of the sham manipulation must be credible.  
Type of Outcome Studies that had a perceived measure of pain as an outcome (e.g. 
VAS pain scores, standardised questionnaires) 
We excluded studies that were not randomised, that used participants with radicular 
symptoms, history of lumbar spine surgery, osteoporosis, spinal stenosis and 
spondylolisthesis or were pregnant. We also excluded any studies that used other 
therapies, drugs, exercise, advice or information as a control or did not include 
sufficient details of the blinding process in the text. A table of excluded studies, with 
reasons for exclusions, can be found in Appendix 3. 
Only completed RCTs were included (reports of ongoing trials were excluded (e.g. 
protocol papers)).  The primary outcome was any measure of pain (both standardised 
and non-standardised). The secondary outcome was any adverse event mentioned. 
Data from included studies were extracted independently by two reviewers (JR, RP) 
using a form with pre-defined criteria.  
The risk of bias (RoB) of all included RCTs was evaluated independently by two 
reviewers (JR, RP) using the Risk of Bias tool of the Cochrane Back Review Group 
(CBRG)36(Appendix 2).  Studies are rated as having a low RoB when ‘at least 6 of the 
CBRG criteria have been met and the study has no serious flaws’ (Furlan et al 2009 
p1932). Disagreements were resolved through discussion with the 3rd reviewer (HS). 
The manuscript was developed using the Preferred Reporting Items for Systematic 
Reviews and Meta-analysis (PRISMA) checklist.37  
  
Meta-analysis 
Meta-analyses were performed in Stata 13 (Stata, College Station, TX), using the user-
contributed commands metan 38 and metafunnel.39 Standardised mean differences 
(SMD) and corresponding standard errors were calculated for included studies using 
means, standard deviations and sample sizes reported in the relevant publications. 
Due to the small sample sizes of some studies, Hedges’ g, an extension of Cohen’s d 
adjusted for small sample bias, was calculated.40 A negative SMD corresponds to a 
lower pain score being associated with the SM group. 
Effect estimates were pooled using a random effects model. Unlike a fixed effects 
model, which assumes that each study estimates the same effect size, a random 
effects model assumes that each study estimates a different effect, but that these are 
drawn from some common distribution.41 Thus, in addition to random sampling error, 
differences may also be due to dissimilarities between study populations and designs. 
The I2 statistic was also calculated, which measures inconsistency between estimates 
and is independent of sample size.42  
 
Post-hoc Sensitivity analysis 
Initially, only studies reporting results at follow up were included in the main analysis, 
using the last follow up time point as comparison. However to maximise comparability, 
the 1 month follow up data from Senna et al’s (2011)43 study was used in this analysis 
(as opposed to the last time point at 10 months). One sensitivity analysis included only 
studies which collected pain measurements immediately post-treatment. A further 
sensitivity analysis investigated the effect of including studies assessed as being at a 
high risk of bias.33  
Dealing with missing data  
Where possible, we extracted the number of participants randomised to a treatment 
arm, the mean pain score, and standard deviation for each group. In some cases, only 
means and standard errors were reported, in which case the group sizes were used to 
estimate the corresponding standard deviation.43 In one case, we were unable to 
extract relevant information from the initial publication, but instead results reported in a 
subsequent review which included this study.33  Where there was insufficient 
information we contacted authors. 
 
 
 
RESULTS 
The literature search identified 1625 potentially relevant titles and abstracts. After 
screening, nine RCTs were identified that met the inclusion criteria for this review.  The 
studies were published from 1986 to 2014.  Five originated from USA,33,44,45,46,89 one 
from Canada,47 one from France,48 one from Egypt43 and one from Germany.49 Eight 
were in English and one in French.48 The total number of participants enrolled was 646 
(252 male, 394 female), the sample size varied from 6 to 145 and age ranged from 18-
65 years. The mean age of participants was incalculable due to incomplete reporting in 
one of the trials.44 Four types of pain outcome measure were used. To assess pain 
levels directly either a Visual Analogue Scale (VAS) or Numerical Rating scale (NRS) 
were used. To assess physical function due to pain either the Oswestry Low Back Pain 
Disability Questionnaire (OLBPDQ) or the Roland-Morris Low Back Pain Questionnaire 
(RMLBPQ) were used. A summary of the main characteristics is presented in Table 1 
and Risk of Bias assessment is presented in Table 2.   
The number of treatments given varied between studies (1 to 12), although two 
studies33,44 did not report the total number.  The two most common methods of SM 
were side lying, long lever rotational thrust or a supine thrust to the anterior pelvis with 
the participant rotated away from the lesion.  Two studies adjusted anywhere along the 
spine.33,45 None of the studies specified which joints were being targeted.  Follow up 
times varied from no follow up to 10 months, with the majority adopting a two week 
follow-up. 
 
Risk of Bias 
Overall, only one study was assessed as having a high risk of bias.33  The remaining 
eight studies were rated as low risk of bias as they achieved a score greater than 6 
(see table 2). For sequence generation, six43,45,46,48,49,80 of the nine trials were assessed 
as having low risk of bias, the risk of bias for the remaining three were unclear.  For 
allocation concealment three were rated as low;46,49,89 the majority were again unclear. 
With regards to blinding of participants, the majority of studies were assessed as low 
risk of bias due to the nature and quality of the sham procedure. Participants also acted 
as outcome assessors when using self-rating scales thus effective blinding of outcome 
assessor was possible. One study45 assessed effectiveness of blinding post-
intervention and found a higher number correctly guessed group assignment in the SM 
group. Bialosky et al (2014)46 assessed believability of the placebo intervention and 
found that those receiving the placebo were more likely to believe their intervention 
was a sham than those in the SM or enhanced placebo group (63% V 33% P<0.05). 
Kawchuk et al (2009)47 had anesthetised all participants, so blinding was complete 
here.  Blinding of the practitioner was impossible in all trials as they would be aware 
which type of manipulation they were performing.  
 
The remaining criteria (selective outcome reporting, intention to treat analysis, co-
interventions reported, compliance levels assessed) were all rated as low risk of bias. 
 
 
Results from the pain outcome measures 
Six studies33,43,45,48,49,89 used a 100 mm VAS pain measure. Five reported an 
improvement in outcome, with SM groups showing lower levels of pain post-treatment 
and at follow up. One study46 also used an 11 point numerical pain rating scale but no 
difference was found between groups.   
Four studies43,45,46,89 used the OLBPDQ to measure physical function due to pain levels.  
Two studies43,45 reported an improved outcome with SM.  
Senna et al (2011)43 found differences between non-maintained SM and sham group at 
1 and 4 months using the VAS but the mean pain score gradually returned to pre-
treatment levels after the treatment was stopped (1 month). They also found evidence 
of a difference (p=0.005) using the OLBPDQ at 1 month follow up but no other time 
points. In contrast, the maintained SM group continued improving, indicating SM needs 
to be maintained to have a lasting effect.   
Von Heymann et al (2013)49 compared groups receiving SM (plus placebo medication) 
with a sham (plus placebo medication).  However, no formal comparison was made 
between these arms. An interim analysis found the active treatments to be superior, 
after which the sham arm was dropped and the trial continued as a 2-arm study 
comparing only the two active treatments (SM versus a non-steroidal anti-inflammatory 
drug “diclofenac”).   
Waagen et al (1986)33 found improvements in pain measured using the VAS in both the 
experimental group and the control group immediately after the intervention. At the two 
week post-treatment assessment there was evidence of reduced pain in the 
experimental group only.  
One study47 of just six participants, used an 11-point scale to measure pain. The 
authors report a greater proportion of the SM group experiencing less pain, however 
they do not report any formal analysis. 
Triano et al (1995)89 found evidence of a difference in functioning levels due to pain 
(OLBPDQ) between the three treatment arms at immediately post-treatment (p=0.012), 
with SM reporting the lowest scores. There was no difference between groups at the 
two week follow up. The VAS showed a similar pattern of results, although there was 
no longer evidence of an effect at two weeks. 
Hoiiris et al (2004)45 reported a decrease in pain and disability scores using the VAS 
and the OLBPDQ from baseline to 2 week follow up in all treatment arms.  The SM 
group showing the greatest decline in scores. They found weak evidence of a 
difference between the change for each group (P= 0.087) using the OLBPDQ. Hadler 
et al (1987)44 used the RMLBPQ to assess outcomes and reported evidence of an 
effect of SM among participants who had suffered with NSLBP between 2-4 weeks at 
the 3 day follow up but not at any other time point. 
Drop outs were described and acceptable (<10%) in five studies. Four studies had high 
dropout rates (>10%)33,43,49,89 three of which indicated the control group had the largest 
dropout rate.33,43,49  
Adverse events 
Only three trials reported on adverse events. Senna et al (2011)43 reported that the 
most common adverse events were local discomfort and tiredness, which had resolved 
within 24 hours.  The other two papers just stated that none were reported.47,49  
The effect of the intervention 
The effect of SM for NSLBP as measured by the 100mm VAS is presented in the 
summary of findings table (table 3). From four studies43,45,48,89 (287 participants) the 
SMD is -0.36 (95%CI: -0.59,-0.12).The quality of evidence is graded as low due to high 
drop out in two studies,43,89 broken blinding in one study,45 no practitioner could be 
blinded in any study and only one48 study conducted intention-to-treat (ITT) analysis. 
 
Meta-analysis 
Of the nine included studies, five33,43,45,48,89 reported results of the VAS sufficiently for 
inclusion in a meta-analysis, with four included in the main meta-analysis and five 
included in either of the two sensitivity analyses.  
Each of the following studies recorded information at either two week45,89 or one month 
follow up.43,48 These four studies were the only ones with sufficient information for 
inclusion in the main meta-analysis. After combining effect estimates using a random 
effects model, we found a pooled SMD of -0.36 (95% CI: -0.59,-0.12), corresponding to 
a reduction in pain among participants in the SM group at follow up. The I2 statistic 
suggests no strong evidence against the assumption of homogeneity between effect 
estimates (I2 <0.1%, p=0.835). However, given that there are only four studies included 
in this analysis, caution should be taken making inferences based on these analyses 
(see Fig 2).  
Three studies45,48,89 reported information collected immediately post-treatment and this 
was analysed in a sensitivity analysis (Fig A1). Waagan et al (1986)33 was excluded 
from the main meta-analysis due to having high risk of bias score (see table 4), but 
included in a sensitivity analysis (Fig A3). 
 
 
Fig 2. Forest plot of meta-analysis looking at pain scores of participants receiving SM vs sham 
SM treatment   
 
 
Given the small number of studies included in this analysis, it is difficult to infer too 
much from the funnel plot, although there is no clear indication of small study effects 
(see Fig A5 in appendix). 
Sensitivity analyses 
The analysis run using the post-treatment pain scores show a similar pattern to the 
follow up scores, with a consistent direction of effect and an attenuated estimate (SMD 
= -0.35, 95% CI: -0.61, -0.08) (see Fig A1).  
Analysis run including Waagen et al. (1986),33 assessed to be high risk of bias, found 
results consistent with the main analysis (SMD = -0.37, 95% CI: -0.60, -0.14) (see Fig. 
A3). 
Forest and funnel plots for the sensitivity analyses can be found in Appendix 4 (Figs 
A1-A5). 
 
 
 
DISCUSSION 
The objective of the present review was to systematically identify and critically evaluate 
the evidence from RCTs of spinal manipulation compared to an effective sham placebo 
on NSLBP. This is the first review to compare SM to an effective control. The review 
included nine studies of which four were included in the meta-analysis.  The majority of 
trials used either a 100 mm VAS to assess pain levels or the OLBPDQ/RMLBPDQ to 
assess physical function due to NSLBP. 
The results of the meta-analysis suggests a greater reduction in pain scores among 
participants receiving SM in comparison to those receiving an effective sham placebo. 
This finding remained consistent when looking at pain recorded at immediately post-
treatment and follow up. The pooled effect estimate of -0.36 (95% CI: -0.59, -0.12) 
indicates that those receiving the SM had less pain (a mean of 0.36 standard 
deviations lower) than those in the control group. In terms of clinical relevance, this is 
only a small to moderate effect,50,65 and the confidence intervals are wide. Caution is 
needed before drawing conclusions as most studies had some degree of risk of bias by 
failing to report on randomisation procedure or on allocation concealment.   
Several methodological issues need to be considered. Seven trials which reported no 
evidence of between group differences may have lacked power; as sample sizes were 
small33,43,44,46,47,48 and did not report a priori power calculations. Four studies had high 
dropout rates (>10%),33,43,49,89  three of which indicated the control group had the 
largest dropout rate.33,43,49  This could indicate dissatisfaction with sham as opposed to 
SM which may be an indicator of some treatment effect of SM. Just two studies 
described reasons for drop outs.45,49  One study46 included patients with any duration or 
type of NSLBP which again may have confounded the results. 
Several studies had additional issues with the control group used, which might have 
contributed to the direction of results. Waagen et al (1986)33 used massage as part of 
the control intervention; as massage has specific treatment (and contextual) effects51 
this may have reduced the observable difference between groups. Although the 
participants were screened for previous experience of SM (therefore justifying its 
inclusion in the review), this active control needs to be taken into consideration when 
evaluating the findings. Hoiiris et al (2004)45 used an additional placebo medicine in 
both groups which may have lessened any relative difference.  
Only four studies44,45,46,49 attempted to standardise the interaction between patient and 
practitioner to reduce any placebo effect by way of contextual factors.26,27,52,53 All other 
studies did not control for these variables, weakening their findings. There was much 
variation in number of treatments given and timing of outcome assessments between 
studies, making application to practice more difficult to establish. The majority of 
studies either had no follow up or just two weeks post intervention; a longer follow up 
would be required to ascertain long-term effectiveness of the intervention.  
 
Limitations of the Review 
 Although the search strategy was comprehensive it is possible that some published 
clinical trials may not have been identified.  However, our systematic and detailed 
search strategy make this unlikely, it is more likely that we did not identify eligible 
unpublished trials. Publication bias is a problem in all medical research54 and it is a 
particular problem in alternative medicine.55,56  
Furlan et al (2009)36 recommend studying NSLBP in groups determined by the duration 
of symptoms as there are differences in the clinical course depending on the length of 
time symptoms have been present.  However, this was not possible in this review given 
the limited number of trials that met the inclusion criteria. 
 
Deviations from the protocol 
We conducted two post-hoc sensitivity analyses which were not planned or originally 
stated in the protocol but were deemed important once data was extracted.  One was 
to include studies of high risk of bias33 and the other was to see if there was a 
difference at immediately post–intervention compared to last follow up (using one 
month data rather than the 10 month follow up data for consistency43). There was very 
little variation in the findings. Functional outcomes (RMLBPDQ and OLBPDQ) due to 
pain levels were also extracted as it was deemed further indication of pain levels. 
 
Adverse Events 
Poor reporting of adverse events is a frequent criticism of complementary and 
alternative medicine (CAM) research.57 Several previous reviews on complications of 
SM emphasise its safety,58,59 however serious adverse events have been reported.19 In 
this review few studies reported on adverse events at all. In one study,47 the potential 
for adverse events to occur was higher as they used anaesthetic to ensure adequate 
blinding of participants; this procedure may be considered an unnecessary risk. 
 
Recommendations for Future Research 
Manual therapy practitioners are under pressure to produce evidence for their 
interventions.16,17,60,61,62 Despite Ernst and Harkness’ (2001)17 call for more trials to 
demonstrate the efficacy of SM for NSLBP, very few have been conducted that would 
satisfy the criteria of ‘adequately designed sham-controlled trials’.  In order to respond 
to this challenge this review suggests several directions of future research.   
Treatment and sham interventions should be clearly specified, physically similar and 
matched for number, duration and interaction between subject and practitioner; these 
elements should be recorded. Co-interventions should also be avoided as they can 
distract from any benefits of specific treatment effects. The improvements in trial design 
would reduce the possibility of outcomes being due to non-specific effects. A standard 
measure should be used across studies to allow comparison of results and to facilitate 
formal pooling.  A scale such as the VAS63,64 has been shown to be reliable.  A 
numerical rating scale measuring 0-10 has also been recommended90 (NIH 2014). All 
adverse events should be recorded and reported. If no adverse events occurred this 
should be noted to allow accurate estimation of risks to participants.  
Application to Practice 
Several reviews have concluded suggesting that SM is no more or less effective than 
other treatments with proven benefits for NSLBP.30,66  SM may carry a greater risk of 
adverse events, unlike non-thrust mobilisation5 and massage.51 Our review, however, 
found evidence for an effect of SM over effective control.  There is currently insufficient 
evidence to inform practice.  The decision to receive SM needs to be made by the 
patient who should be made aware of the current uncertainty. 
 
Conclusions 
There is some evidence from four of the nine trials (287 participants) that SM has 
specific treatment effects and is more effective at reducing NSLBP when compared to 
an effective sham intervention.  Although the effect was small-medium in terms of 
clinical relevance, a similar effect was found both immediately post-treatment and at 
follow up. Inconsistency of results across all studies may be due to the use of different 
interventions, controls, outcome measures and variable standards of methodology 
between studies. Currently, the evidence is insufficient to inform practice.  Further 
adequately powered, well designed studies are required. 
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TABLE 1: characteristics of selected studies 
Study 
Country 
 
Sample size (analysed) 
Intervention: Sham   
Age range/Mean  age (SD)SE* 
Sex 
Study setting/ 
participants 
 
SM Sham control No. of treatments 
 
 
Pain outcome measure 
 
Assessment schedule 
Waagen et 
al (1986)33 
USA 
N = 29 (19) 
SM: N = 11 Age = 25.2 (NR) 
Sham: N=18 Age = 24.3 (NR) 
1st time patients at a chiropractic 
college clinic with pain of > 3 weeks 
duration. Patients naïve to 
chiropractic care 
High velocity thrust to all levels of 
spine 
Lumbar drop piece on chiropractic table 
set to mimic thrust, followed by soft 
tissue manipulation  
2-3 treatments 
/week for 2 weeks 
with discrepancies 
between groups 
Pain: 10cm VAS  
 
BL 
Post- treatment at 2weeks 
Hadler  et 
al  
(1987)44 
USA 
N = 57 (54) Age = 18-40 
SM: N = 26 Males = 18 
Sham: N = 28 Males = 13  
Pps experiencing NSLBP for 1st time 
and no longer than 1 month, 
groups stratified by NSLBP < 2 
weeks and 2-4 weeks  
Side-lying long lever rotational 
thrust to lumbar spine, no levels 
specified 
Side-lying with both knees flexed, light 
thrust delivered to hips  
Not specified 
 
FU every 3 days by 
phone for 2 weeks 
Pain: RMLBPDQ 
BL 
Every 3 (±1) days from treatment 
(4 questionnaires in total) 
Triano et al 
(1995)89 
USA  
 
N= 209 (145)$  Age = 42.3 (14.3) 
Male= 83: Female = 62 
SM: N= (47) 
Sham: N=  (39)  
107 in SM or control groups 
completed (43 in back education 
group) 
Pps presenting to back clinic who 
had suffered > 50 days of NSLBP or 
had a history of > 6 episodes of 
NSLBP 
Side-lying long lever rotational 
manipulation, no levels specified 
Side-lying with both knees bent, thrust 
delivered to a supported area of the 
thoracic spine 
7 or more, with 
discrepancies 
between groups 
Pain: 10cm VAS, OLBPDQ 
 
BL 
Post-treatment 
2 wk FU 
Hoiiris et al 
(2004)45 
USA 
N=192 enrolled $ 
N =103 in SM or control groups 
completed (53 in muscle relaxants 
group) 
SM: N=50 (34) Age = 42.2 (9.7) 
Males: 25 
Sham: N=53 (40) Age = 43.1 (9.8) 
Males: 32 
Pps had sub-acute NSLBP between 
2-6 wks duration 
Variable adjustments, prone or 
side-lying for all spine 
 + placebo medicine 
Prone or side-lying positioning with 
practitioner contact and motion with no 
thrust + placebo medicine 
  
7 treatments for 
each group, over 2 
weeks 
Pain: 10 cm VAS, OLBPDQ 
 
 BL  
 post-treatment, 
 2 wk FU 
Ghroubi 
et al 
(2007)48 
France 
 
N= 64  
SM: N=32 Age = 39.06 (11.05) 
Males = 5 
Sham: N=32 Age = 37.37 (7.51) 
Males = 8 
Pps presented with first episode of 
NSLBP of ≤ 6 months  
Spinal manipulation, no levels 
specified 
Side lying “tensioning of the spine” 
without thrust 
4 treatments for 
each group 
Pain: 10cm VAS  
 
 BL  
 Post treatment 
 1 month FU 
Kawchuk et 
al 
(2009)47 
Canada 
N = 6 Age = 36.5 (NR) 
Males = 4 
SM: N=3 
Sham: N=3 
Pps with uncomplicated NSLBP <2 
weeks duration currently receiving 
lumbar SM 
Anesthetised for 3-5 mins and then 
received a single SMT to lumbar 
spine 
Anesthetised for 3-5 mins 1 treatment Pain: 11 point scale (0-10) 
 
Before anaesthetic and 30 mins 
after recovery 
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Senna et al 
(2011)43 
Egypt 
N=67 
SM: N=26 Age = 40.3(11.67) 
Male:19, Female:7,  
Sham: N=37  Age= 42 (9.66) 
Male:28, Female:9, 
 SM Maintained:  N=25,  Age = 41 
(11.03) 
Male:19, Female:6 
Pps between 20-60 yrs suffering 
NSLBP >6 months. 
SM + Maintained SM - Supine, 
patients side bent towards and 
rotated away from the lesion, a 
thrust forces applied to the 
anterior pelvis in a posterior and 
inferior direction.  Followed by 
posterior pelvic tilt exercises. 
SM techniques, which consisted of 
manually applied forces of diminished 
magnitude, aimed purposely to avoid 
treatable areas of the spine and to 
provide minimal likelihood of therapeutic 
effects.  Followed by posterior pelvic tilt 
exercises 
12 treatments over 
a 1 month period  
 
Maintained SM 
group– 2x month 
for 9 months. 
Pain: 10cm VAS ,OLBPDQ 
 
 BL1 month (following 12 
treatments), 
 4 month FU 
 7 month FU  
 10 month FU 
 
Von 
Heymann 
et al  
(2013)49 
Germany 
N= 100 
SM:38(33) 
 Median age 34.14 (9.45) Male:24, 
Female:14 
Diclofenac 37(33) 
median age 37.51(10.09)  
23M, 14 F 
Sham: 25(14) 
median age 39.25(10.23) Male:13, 
Female:12 
Pps between 18-55 yrs with NSLBP 
with duration <48hours, recruited 
from outpatient practices. 
Side lying rotational thrust 
technique, no levels specified. + 
Placebo tablets 
Patient prone, one leg tractioned, a 
cephalad impulse is delivered through the 
sacrum, on the opposite side to the 
sacrum.  + Placebo tablets. 
2-3 over 1 week 
 
Pain: 10cm VAS, RMLBPDQ 
 
 BL 
 7-9 days post intervention 
 
Bialosky et 
al  (2014)46 
USA 
N=95 77 F, 33M 
Overall mean age 31.68 
SM: 28 Male: 7 , Female:21 
Sham:27 Male:10, Female:17 
Enhanced Sham SM: 27 Male:7, 
Female:20) 
NO ITT – 28 (F19, M9) 
Pps between 18-60 yrs, suffering 
NSLBP ≥  4/10 over 24hrs on NRS 
Supine, side bent towards and 
rotated away from the lesion, a 
thrust forces applied to the 
anterior pelvis in a posterior and 
inferior direction.  No levels 
specified 
Sham - Supine, no side bending, patient 
rotated away from the lesion then 
returned pre thrust, the thrust was 
delivered into the table. 
Enhanced sham– same physical procedure 
+ suggestion to patient of the benefits of 
the sham procedure. 
6 times over 2 
weeks, each visit -  
SM: 2 each side 
Sham: 2 each side 
Enhanced Sham: 2 
each side. 
Unusual pain NRS (0-10) OLBPDQ  
 
 BL 
 at end of study (2 weeks 
duration) 
SD = standard deviation; SE = standard error;  Pps=participants; SM= Spinal manipulation; N = number; mins.= minutes; FU = follow up: NSLBP = non-specific low back pain; M = male; F = female; OLBPDQ – 
Oswestry Low back pain disability questionnaire;  RMLBPDQ = Roland Morris Low Back Pain Disability Questionnaire; VAS = visual analogue scale; NRS= numerical rating scale; NR – not reported, BL – 
baseline; $ = 3 groups included in all analyses 
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Table 2: Risk of bias table (Cochrane Back Review Group, 2009) 
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Waagen 198633 
 
? ? YES NO YES* NO NO YES YES NOe NO (66%)j YES 5 
Hadler 198744 
 
? ? YES NO YES* YES** NO YES YES YES YES (95%)j YES 8 
Triano 199589 
 
YES YES YES NO YES* NO NO YES YESh YES YES (81%)j YES 9 
Hoiiris 200445 YES ? NOi NOa NOi* YES NO YES YESb YESc YES 
(79/82%)k 
YES 7 
Ghroubi 200748 YES 
 
? YES NO YES* YES YES YES YES YES YES (100%)j YES 10 
Kawchuk 200947 ? ? YES NO YES* YESf YES YES ? YES YES (100%)j YES 8 
Senna 201143 YES ? YES NO YES* NO described but 
unacceptable 
NO YES YES YES YES (94%) YES 8 
Von Heymann 
201349 
YES YES YES NO YES* NO NO ? YES YES NO (75%) YES 7 
Bialosky 201446 
 
YES YES YES NO NO YES YES YES YES YES YES (100%) YES 10 
* Outcome assessor is participant when rating self-report scales like the VAS, RMLBPDQ (Roland Morris Low Back Pain Disability Questionnaire), OLBPDQ (Oswestry Low back pain disability   
Questionnaire) 
 ** <10%; YES =1, NO = 0, ? = unclear 
a = although authors claim the chiropractor was blinded – this would be impossible; b = between the Intervention and sham; c= both also received placebo medicine; d = differences in number of 
treatments over differing duration periods; e= soft tissue performed in sham group only; f = no dropouts; g= no mention of analysis; h= some analysis of height and weight; i= blinding of 
participant was tested and perception of true chiropractic care was sig. higher in chiropractic group (P<0.05); j = the authors did not report compliance directly so we have inferred compliance 
from people completing the treatment programme; k = based on medication logs or kits respectively. 
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 Table 3: Summary of findings table: Spinal manipulation versus an effective sham for non-specific low back pain 
 Patient or population: Individuals with NSLBP 
 Settings: Clinic 
 Intervention: Spinal manipulation using high velocity/low amplitude thrust 
 Comparison: Effective sham manipulation 
Outcomes Illustrative comparative risks* (95% CI) No of Participants  
(studies) 
Quality of the evidence 
(GRADE) 
Comments 
Assumed risk Corresponding risk 
Control group Intervention group 
Pain (as measured by a 
100mm VAS) 
Follow up 2 weeks to 1 
months) 
 
 
The mean pain 
symptomology 
(continuous) in the 
intervention groups was 
0.36 standard 
deviations lower (0.59 
to 0.12 lower) 
287  
(4) 
⊕⊕⊝⊝1 
low 
Low risk of bias in 
outcome reporting as 
participants were 
blinded effectively2 
 
Small to moderate 
SMD = -0.36 (95% CI: -
0.59, -0.12) 
 
CI = Confidence Interval 
 
 GRADE Working Group grades of evidence 
 High quality: Further research is very unlikely to change our confidence in the estimate of effect 
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate 
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate 
 Very low quality: We are very uncertain about the estimate 
 
1 Judgements of low risk of bias (>6) in all studies included in the main meta-analysis, however high level of dropouts in 2 studies, no ITT analysis in 3 studies, all practitioners 
could not be blinded 
 2 The sham manipulation ensured blinding of participants, although one45 tested blinding and it is possible it may have been broken
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Table 4 – Results of VAS pain scores included in meta-analysis 
 
 Post-treatment   Follow up 
 Intervention Control Intervention Control 
Study N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) 
1. Waagen et al. (1986) - - - - 9 23 (15) 10 31 (15) 
2. Triano et al. (1995) 47 13.9 (15.3) 39 19.8 (18.3) 47 13.3 (15.9) 39 21.7 (24.4) 
3. Hoiiris et al. (2004) 34 2.44 (2.22) 40 3.18 (2.4) 34 1.71 (1.88) 40 2.21 (2.02) 
4. Ghroubi et al. (2007) 32 49.37 (16.78) 32 58.43 (28.8) 32 48.13 (22.78) 32 54.43 (25.76) 
5. Senna et al. (2011) - - - - 26 29.5 (6.03) 37 33.2 (7.53) 
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Appendix 1 - Search Strategy 
 
Terms recommended by Furlan et al (2009) 
1. exp Back Pain/ or exp Low Back Pain/ 
2. exp Lumbar Vertebrae/ 
3. Zygapophyseal Joint/ 
4. (back adj3 pain).ti,ab. 
5. (low* adj3 back adj3 pain*).ti,ab. 
6. (lumbar adj3 vertebrae*).ti,ab. 
7. ((backache or back) adj3 ache).ti,ab. 
8. lumbago*.ti,ab. 
9. (facet adj3 joint*).ti,ab. 
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 
11. exp Manipulation, Spinal/ 12. exp Manipulation, Osteopathic/  
13. (sham adj3 manipulation*).ti,ab. 
14. (spin* adj3 manipulation*).ti,ab. 
15. (osteopath* adj manipul*).ti,ab. 
16. (high adj3 velocit* thrust).ti,ab. 
17. (spin* adj3 adjust*).ti,ab. 
18. 11 or 12 or 13 or 14 or 15 or 16 or 17  
19. exp Randomized Controlled Trial/  
20. exp Controlled Clinical Trial/ 
21. exp Random Allocation/  
22. random$ allocat$.ti,ab. 
23. (randomi?ed adj3 controlled adj3 trial).ti,ab. 
24. (controlled adj3 clinical adj3 trial).ti,ab. 
25. random$.ti,ab. 
26. placebo$.ti,ab. 
27. exp Placebos/ 
28. exp Clinical Trial/ 
29. trial.ti,ab. 
30. group$.ti,ab. 
31. 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30  
32. 10 and 18 and 31 
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Appendix 2 - Risk of Bias Tool (Furlan et al,  2009) 
A 1 Was the method of randomization adequate? yes/no/unsure 
B 2 Was the treatment allocation successful? yes/no/unsure 
C  
Was the knowledge of the allocated interventions adequately prevented 
during the study? 
 
 3 Was the patient blinded to the intervention? yes/no/unsure 
 4 Was the care provider blinded to the intervention? yes/no/unsure 
 5 Was the outcome assessor blinded to the intervention? yes/no/unsure 
D  Were incomplete outcome data adequately described?  
 6 Was the drop out rate described and acceptable? yes/no/unsure 
 7 
Were all randomised participants analysed in the group to which they 
were allocated? 
yes/no/unsure 
E 8 
Are reports of the study free of suggestion of selective outcome 
reporting? 
yes/no/unsure 
F  Other sources of potential bias  
 9 
Were the groups similar at baseline regarding the most important 
prognostic factors? 
yes/no/unsure 
 10 Were co-interventions avoided or similar? yes/no/unsure 
 11 Was the compliance acceptable in all groups? yes/no/unsure 
 12 Was the timing of the outcome assessment similar in all groups? yes/no/unsure 
  Total score = no of yes answers    /12  
    
The risk of bias for RCTs was assessed using the criteria list recommended in the Updated Method 
Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group.  
 
Scores of 6 or more were considered low risk of bias 
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Appendix 3 – Studies excluded  
 
STUDY REASON EXCLUDED 
Clark et al 200967 No sham manipulation in control group. 
Cleary and Fox 199468 Fox's 'low force osteopathic technique' does not match the 
inclusion criteria for an HVLA manoeuvre 
Cleland et al 200669 No sham control, comparison groups are alternative 
manipulation or mobilisation. 
Cote et al 199470 No sham control, comparison group is a mobilisation 
Cramer et al 200271 No sham control, comparison group is side lying positioning 
Dishman et al 200272 No sham control, comparison group is side lying positioning 
Hancock et al 200773 No sham control, placebo is detuned ultrasound therapy 
Hancock et al 200874 No sham control, placebo is detuned ultrasound therapy 
Hawk et al 200575 Excluded due to paper's own assessment of inadequate blinding 
Hoehler et al 198176 No sham intervention, massage was used as the control. 
Hondras et al 199977 Participants not generalizable  
Hondras et al 200934 No sham control, comparison groups are low force 
manipulations, minimal medical care and exercise therapy 
Kokjohn et al 199278 Participants not generalizable 
Krekoukias et al  200979 No sham control, comparison groups are prone lying and prone 
lying with touch onto L3 spinal level 
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Learman et al 200980 Although the subjects were extensively screened for pain levels 
at entry to the study, no follow up data measuring pain was 
assessed. 
Licciardone et al 200332 Several different and non-standardised interventions (muscle 
energy techniques, soft tissue manipulation, fascial manipulation 
and cranio-sacral) were made both in the treatment group, the 
sham group received 'fake' treatments in the same modalities.   
Licciardone et al 201381 Several different and non-standardised interventions (muscle 
energy techniques, soft tissue manipulation, fascial manipulation 
and cranio-sacral) were made both in the treatment group, the 
sham group received 'fake' treatments in the same modalities.    
Ongley et al 198782 As well as a spinal manipulation, painkilling injections were being 
administered, in the control group the amount of painkilling 
injection was lowered therefore influencing reported pain levels 
Mandara et al 200883 No full data available, abstract is published as a conference 
presentation, repeated attempts were made to contact the 
authors with no response. 
Perry and Green 200884 No measurement of pain as an outcome 
Puetendura et al 201085 No measurement of pain as an outcome 
Roy et al  200986 although groups were divided into pain and pain free, no 
measurement of pain was taken. 
Santilli et al 200687 Radicular symptoms present 
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Appendix 4 – Forest and funnel plots from sensitivity analyses 
A1-A5 
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Fig 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effective sham as described in the introduction.   
RCT – randomised controlled trial; NSLBP – non-specific low back pain 
Database search of MEDLINE, COCHRANE, 
AMED and WOS, from beginning of records 
March 2015 
1625 retrieved – 1158 after removing 
duplicates 
 
 
Excluded = 1079 
Animal/child/cell = 35 
Not lumbar spine = 162  
No control group = 121 
Radicular symptoms or other 
pathology = 13 
Not manipulation =158  
No effective sham* = 216  
No pain measure = 9Other (not 
relevant) = 178  
Other reviews=187  
 
79 full texts retrieved for further 
assessment 
Excluded = 70 
 
Not RCT = 5 
Not lumbar spine = 2 
Radicular symptoms or other pathology 
= 1 
Not manipulation = 17 
No effective sham* = 18 
No pain measure = 9 
 Other review = 7 
Letter/commentary = 9 
 not NSLBP = 2 
 
       9 studies included 
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Fig 2. Forest plot of meta-analysis looking at pain scores of participants receiving SM vs sham SM 
treatment  
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Fig A1. Forest plot of meta-analysis looking at pain scores of participants receiving SM vs sham SM 
treatment when assessing pain scores immediately post-treatment  
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Fig A2. Forest plot of meta-analysis comparing SM vs sham SM treatment as assessed at follow up 
when including Waagen et al. (1986)  
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Fig A3. Funnel plot of studies comparing SM vs sham SM treatment when assessing pain scores 
immediately post-treatment 
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Fig A4. Funnel plot of studies comparing SM vs sham SM treatment as assessed at follow up when 
including Waagen et al. (1986)  
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Fig A5. Funnel plot of studies comparing SM vs sham treatment  
 
 
 
0
.0
5
.1
.1
5
.2
.2
5
s
e
(S
M
D
)
-.8 -.6 -.4 -.2 0 .2
SMD
Funnel plot with pseudo 95% confidence limits
